Company Overview
NueCura Partners, LLC is a Nashville-based angel investment firm specializing in early-stage investments within the healthcare sector. Founded by seasoned professionals from the healthcare industry, NueCura leverages its expertise to identify and nurture promising healthcare-related businesses. The firm emphasizes the sectors and companies it believes align strategically with its vision to transform the healthcare landscape.
Strategic Approach and Investment Philosophy
NueCura Partners focuses on investing in early-stage healthcare companies with transformational potential through financial support and operational mentorship. The firm is committed to:
- Building a diverse membership body with extensive industry expertise to facilitate informed investment decisions.
- Providing a platform for affiliate investors to efficiently engage in investment opportunities.
- Collaborating with other venture capital and angel groups to enable syndicate investments, promoting investment integrity and transparency.
Leadership Team
The leadership of NueCura Partners consists of highly experienced individuals in healthcare and investments:
- Don Lazas, MD - Founder and Managing Partner
- Ted Sanft - Co-Founder and Operating Partner
- Tony Corley, MBA - Managing Partner and CFO
- Bill Gates, MD - Operating Partner
- Chris Taylor - Operating Partner
- Jeff Patton, MD - Senior Advisor
This team enhances NueCura's capacity to support groundbreaking ventures in healthcare.
Investment Portfolio and Impact
NueCura has strategically invested in numerous influential companies, including EvidenceCare, LeanKit, and NextGxDx. Their investment approach goes beyond financial support, providing strategic guidance and leveraging industry connections to foster growth and impact in the healthcare field.
Financial Data
NueCura Partners reports an annual estimated revenue of $2.2 million and maintains a workforce of 16 employees, reflecting stable operations with a 0% growth rate over the past year. The estimated revenue per employee stands at $136,200.
Key Affiliates and Testimonials
The firm receives endorsements from its partner companies, underlining the value of NueCura's expertise:
- The CEO of EvidenceCare appreciates the critical funding and healthcare thought leadership.
- The CEO of RxRevu acknowledges the collaborative investment experiences and mentorship.
- The CEO of Sano Informed Prescribing values the strategic focus and seasoned expertise brought by NueCura.
Competitor Profiling
NueCura Partners operates in a competitive landscape with key competitors such as:
- Dynamic Wealth Advisors: Registered investment advisor managing a significant portfolio valued at $4.8 billion.
- Mercer Advisors: Generates annual revenue of $329.2 million with 1,014 employees, specializing in financial planning and wealth management.
- Tortoise Capital Advisors: Manages $8.6 billion in assets, focusing on energy and power infrastructure.
- Angel Oak Companies: Offers asset management, mortgage lending, and investment advisory services, employing 501 to 1000 people.
- Monarch Private Capital: Engaged in tax equity impact investments, managing over $6 billion in projects.
Strategic Insights
NueCura’s niche specialization in healthcare angel investments allows it to efficiently navigate and target the healthcare market. While the company maintains a steady workforce, exploring growth initiatives and insights from competitors could enhance scalability and diversification of investment strategies to expand its revenue streams and market impact effectively.
